Reumatología Clínica (English Edition) Reumatología Clínica (English Edition)
Reumatol Clin 2016;12:354-5 - Vol. 12 Num.6 DOI: 10.1016/j.reumae.2015.11.016
Images in Clinical Rheumatology
Rowell's Syndrome: The Two Sides of the Truth
Síndrome de Rowell: las 2 caras de la verdad
Juan Francisco López Caleyaa,, , Laura Martín Rodrigob, Pablo Gonzalvo Rodriguezc, Yolanda Hidalgo Garcíad
a Servicio de Medicina Interna, Hospital de Cabueñes, Gijón, Asturias, Spain
b Servicio de Medicina Interna, Fundación Hospital de Jove, Gijón, Asturias, Spain
c Servicio de Anatomía Patológica, Hospital de Cabueñes, Gijón, Asturias, Spain
d Servicio de Dermatología, Hospital de Cabueñes, Gijón, Asturias, Spain
Received 18 September 2015, Accepted 05 November 2015

In 2000, Zeitouni et al. updated the diagnostic criteria of Rowell's syndrome (RS).1,2 They included the development of lupus erythematosus (LE) in its systemic, discoid and subacute cutaneous forms, erythema multiforme (EM) and antinuclear antibodies (ANA) (a speckled pattern) as the more important criteria. Moreover, they associated rheumatoid factor (RF), positive anti-Ro/SS-A or anti-La/SS-B antibodies and pernio (chilblains) as less significant criteria.2

The patient was a 91-year-old woman with a 2-month history of generalized itching and painful dermatitis, with a poor response to corticosteroid therapy. She had not had infections or previous use of these medications.

The physical examination showed a scaly, maculopapular eczema, with crusting areas in trunk and all 4 extremities, creating a typical result has shown (Fig. 1A and B).

Fig. 1.

(A) Scaly, maculopapular eczema on trunk and extremities. (B) Trunk involvement.

The laboratory tests included RF (83.1IU/mL), ANA (1/2560 speckled pattern) and positive anti-Ro/SSA and anti-La/SSB. The skin biopsy was compatible with LE and EM (Fig. 2A and B).

Fig. 2.

(A) Epidermis with vacuolar degeneration of the basal cells (asterisks), isolated necrotic keratinocytes (arrows) and associated lymphocyte infiltrate. The image shows the verticality of the basal cells (arrowheads), a histological feature associated with erythema multiforme. Infiltrated lymphocytes and melanophages in papillary dermis. (B) Reticular dermis with interstitial mucin (asterisks).

For some authors, the coexistence of LE and EM are not considered different entities.3

It is difficult to distinguish between subacute cutaneous LE (SCLE) and EM.4,5 However, other authors insist that the classical EM be acute and self-limited, and that the lesions be bull's-eyes. This is commonly associated with infections and previous drug exposure.6,7

In RS, the typical findings are recurrent, EM-like lesions, with no triggering factors and with positive antibodies and RF.7

The speckled pattern of the ANA is the immunological characteristic most consistent of RS, appearing in 60.4% to of the cases, although it is not exclusive of this condition.8 Therapy should be initiated with corticosteroid and hydroxychloroquine. In some cases, success was obtained with dapsone, cyclosporine or azathioprine.9,10

Although the pathological finding is not a diagnostic criterion, it is indispensable for the identification of this disorder.

The diagnostic criteria should be reviewed in order to limit the forms of LE and to assess the need of EM-like lesions without a known triggering agent as essential.

Ethical DisclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Conflicts of Interest

The authors declare they have no conflicts of interest with regard to this work.

References
1
N.R. Rowell,S. Beck,J.R. Anderson
Lupus erythematosus and erythema multiforme-like lesions
Arch Dermatol, 88 (1963), pp. 176-180
2
N.C. Zeitouni,D. Funaro,R.A. Cloutier,E. Gagne,J. Claveau
Redefining Rowell's syndrome
Br J Dermatol, 142 (2000), pp. 343-346
3
A. Tirado
Síndrome de Rowell o lupus eritematoso sistémico y eritema multiforme:¿correlación o concomitancia?
Reumatol Clin, 2 (2006), pp. 155-157 http://dx.doi.org/10.1016/S1699-258X(06)73038-8
4
K. Aydogan,S.K. Karadogan,S.B. Adim,S. Tunalit
Lupus erythematous associated with erythema multiforme: report of two cases and review of the literature
JEADV, (2005), pp. 621-627
5
V.V. Pai,K. Naveen,S.B. Athanikar,U. Dinesh,P. Reshme,R. Divyashree
Subacute cutaneous lupus erythematosus presenting as erythroderma
Indian J Dermatol, 59 (2014), pp. 634
6
R.Y. Bhat,C. Varma,S. Bhatt,C. Balachandran
Rowell syndrome
Indian Dermatol Online J, 5 (2014), pp. S33-S35 http://dx.doi.org/10.4103/2229-5178.144526
7
S.S. Kim,C. Magro,R.D. Granstein,A. Bass,D. Erkan
Systemic lupus erythematosus associated with Rowell's syndrome
HSS J, 9 (2013), pp. 289-292
8
E. Antiga,M. Caproni,D. Bonciani,V. Bonciolini,P. Fabbri
The last word on the so-called Rowell's syndrome
9
S.L. Cornelia,M.D. Müller,R. Louisa,M.D. Hinterberger,T. Vogt
Succesful treatment of Rowell syndrome using oral cyclosporine A
Int J Dermatol, 50 (2011), pp. 1020-1022
10
M.R. Bhobe,S. Tambe,S. Jindal,H.R. Jerajani
Rowell's syndrome to ds-DNA negative lupus nephritis: a yet unreported progression
Indian J Dermatol, 60 (2015), pp. 215 http://dx.doi.org/10.4103/0019-5154.152608

Please cite this article as: López Caleya JF, Martín Rodrigo L, Gonzalvo Rodriguez P, Hidalgo García Y. Síndrome de Rowell: las 2 caras de la verdad. Reumatol Clin. 2016;12:354–355.

Corresponding author.
Copyright © 2015. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Reumatol Clin 2016;12:354-5 - Vol. 12 Num.6 DOI: 10.1016/j.reumae.2015.11.016